Accès ouvert
2026
article
OpenAlex
Clotilde Allavena, Sean P. Fleming, Colin Deschanvres, Philippe Mariot et autres
Doravirine (DOR)-based regimens are recommended as alternative options for virologically suppressed people with HIV (VS-PWH). However, data supporting their long-term use in real-world settings are scarce. This large study described the long-term effectiveness and safety of DOR-based regimens following treatment switch in …
fr, us, gp, mq
(code pays fourni par la source)
2015
article
OpenAlex
Slim Fourati, Charlotte Charpentier, Corinne Amiel, Laurence Morand‐Joubert et autres
OBJECTIVES: The objectives of this study were to determine the prevalence and patterns of resistance to integrase strand transfer inhibitors (INSTIs) in patients experiencing virological failure on raltegravir-based ART and the impact on susceptibility to INSTIs (raltegravir, elvitegravir and dolutegravir). PATIENTS AND …
fr
(code pays fourni par la source)
Accès ouvert
2014
article
OpenAlex
C. Soulie, D. Descamps, M. Grude, V. Schneider et autres
OBJECTIVES: The neurological disorders in HIV-1-infected patients remain prevalent. The HIV-1 resistance in plasma and CSF was compared in patients with neurological disorders in a multicentre study. METHODS: Blood and CSF samples were collected at time of neurological disorders for 244 patients. …
fr, ch
(code pays fourni par la source)
Accès ouvert
2013
article
OpenAlex
Diane Descamps, D. Descamps, L. Assoumou, M. L. Chaix et autres
OBJECTIVES: As recommended by the French ANRS programme for the surveillance of HIV-1 resistance, we estimated the prevalence of transmitted drug resistance-associated mutations (RAMs) in antiretroviral-naive, chronically HIV-1-infected patients. METHODS: RAMs were sought in samples from 661 newly diagnosed HIV-1-infected patients in …
fr, ch
(code pays fourni par la source)
Accès ouvert
2012
article
OpenAlex
Sandrine Reigadas, S. Reigadas, A.G. Marcelin, A. Houssaini et autres
Sir, The prevalence of natural polymorphisms and mutations associated with integrase (IN) inhibitor (INI) resistance in the HIV-1 IN has already been analysed.1–5 The aim of the study was to characterize the HIV-1 IN variability in antiretroviral (ARV)-naive and -experienced patients, never …
fr, ch, us
(code pays fourni par la source)